Advertisement

Urology General

Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study.

Feb 25, 2020

To prospectively investigate early and consecutive changes of lower urinary tract symptoms (LUTS), specifically storage symptoms after holmium laser enucleation of the prostate (HoLEP).Patients referr...

Relationship between each IPSS item score and erectile dysfunction in the Korean Internet Sexuality Survey (KISS): do men with weak streams have low sexual function?

Feb 25, 2020

The current results show that lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) are co-prevalent conditions. The objective of this study was to determine which LUTS among seven items o...

Association of Angiotensin I Converting Enzyme Insertion/287 bp Deletion Polymorphisms and Proliferative Prostatic Diseases among Lebanese Men.

Feb 25, 2020

Angiotensin I converting enzyme (ACE) insertion (I) and 287 bp Alu repeat DNA fragment deletion (D) polymorphisms have been indicated in various cancers. Here, we investigated I/D polymorphisms in p...

Therapeutic Use of Pulsed Electromagnetic Field Therapy Reduces Prostate Volume and Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia.

Feb 25, 2020

Benign Prostatic Hyperplasia (BPH) etiology remains poorly understood, but chronic low-grade inflammation plays a role. Pulsed Electro Magnetic Field therapy (PEMF) (1-50Hz) are effective in reducing ...

Female Authorship Publishing Trends and Forecasting in Pediatric Urology: Are we Closer to Gender Equality?

Feb 25, 2020

To review the literature of 5 pediatric urology topics and conduct gender based and forecasting analyses of first and corresponding authors.A PubMed search was performed for hypospadias, hydronephrosi...

The basics of transition in congenital lifelong urology.

Feb 25, 2020

Transition in urology is defined by the process that allows an adolescent or a young adult with a congenital or acquired urogenital anomaly to assume increasing responsibility for their own health car...

Combining Drive Time and Urologist Density to Understand Access to Urologic Care.

Feb 25, 2020

To improve our understanding of timely access to urologic care, we leveraged driving time combined with a measure of urologist density.We identified all urologists who billed Medicare using National P...

Correlation of Relative Value Units with Surgical Complexity and Physician Workload in Urology.

Feb 25, 2020

To define the relationship between urology RVUs and measures of surgical complexity and physician workload. Secondary objectives include: 1) identifying procedures with outlying RVU values for their m...

Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.

Feb 25, 2020

This study was undertaken to determine the safety and efficacy of fexapotide triflutate (FT) 2.5 mg and 15 mg for the treatment of Grade Group 1 prostate cancer.Prospective randomized transrectal in...

Developing evidence-based guidance for assessment of suspected infections in care home residents.

Feb 18, 2020

The aim of this study was to update and refine an algorithm, originally developed in Canada, to assist care home staff to manage residents with suspected infection in the United Kingdom care home sett...

Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.

Feb 18, 2020

Evidence supports the implementation of outpatient parenteral antimicrobial therapy (OPAT) as standard of care. Until 2015 the overall experience with OPAT in Belgium remained limited. The aim of this...

Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative Infections.

Feb 18, 2020

Imipenem-cilastatin-relebactam (IMI-REL) is a novel β-lactam-β-lactamase inhibitor combination recently approved for the treatment of complicated urinary tract infections (cUTIs) and complicated int...

Dutasteride in the long-term management of stuttering priapism.

Feb 18, 2020

The objective of this study is to review our 12-year experience with the 5-α reductase inhibitor dutasteride as a potential long-term treatment option for stuttering priapism. Dutasteride has a uniqu...

Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?

Feb 18, 2020

Phosphodiesterase-5 inhibitors (PDE5Is) are used to treat erectile dysfunction (ED). Recently, the antidepressant-like effect of PDE5Is was demonstrated in animal models of depression. In clinical set...

Ultrasonography after pharmacological stimulation of erection for the diagnosis and therapeutic follow-up of erectile dysfunction due to cavernovenous leakage.

Feb 18, 2020

The goal of this work was to demonstrate that Doppler ultrasound (DUS) after pharmacological stimulation of erection (PSE) can be used to evaluate the presence and intensity of a cavernovenous leak (C...

Testicular function and sexuality in adult patients with anorectal malformation.

Feb 18, 2020

To collect data on sexual and fertility issues in adult male patients with history of anorectal malformations (ARM).Thirty adult males born with ARM, cared for at the Pediatric Surgery of Treviso and ...

The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT Trials.

Feb 18, 2020

Despite limited human data, there is a growing interest in the use of stem cell therapy (SCT) for erectile dysfunction (ED).To determine the effect of transendocardial stem cell injection on erectile ...

Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI-RS 2019.

Feb 18, 2020

Several studies indicate that pelvic ischemia and oxidative stress may play a significant role in lower urinary tract dysfunction (LUTD), including detrusor overactivity (DO)/overactive bladder (OAB) ...

Late onset hypogonadism (LOH): Prostate safety.

Feb 18, 2020

There have always been concerns regarding Testosterone Replacement Therapy (TRT) and prostate safety because of the central role of Testosterone (T) in prostate tissue. Even though there is a body of ...

Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials.

Feb 18, 2020

We performed a post hoc analysis of data from phase 3 and 4 studies to evaluate the efficacy of silodosin 8mg in patients with severe lower urinary tract symptoms (LUTS) related to benign prostatic ob...

SUBSPECIALTIES

Advertisement